BioHealth News Archive
Wendy Buckland to Join Emmes as Chief Operating Officer
New COO Adds International Experience and Clinical Operations Depth to Emmes' Portfolio ROCKVILLE, Md., Dec. 15, 2022 /PRNewswire/ -- Emmes, a global, full-service Clinical…
Read More
Novavax proposes $250M in stock and debt offerings – Washington Business Journal
The Gaithersburg biotech, which also detailed changes to a U.K. sales agreement for its Covid vaccine, saw its share price drop in after-hours trading.…
Read More
PharmaJet Partner Immunomic Therapeutics Receives FDA Fast Track Designation for pDNA Vaccine for Skin Cancer
Vaccine exclusively delivered with the PharmaJet Stratis® Needle-free Injection System December 13, 2022 11:00 AM Eastern Standard Time GOLDEN, Colo.–(BUSINESS WIRE)–PharmaJet®, a company that engineers…
Read More
Emmes Hires Ching Tian in New Leadership Role to Accelerate Innovation
ROCKVILLE, Md., Dec. 14, 2022 /PRNewswire/ -- Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and…
Read More
Phlow Corp., U.S. Pharmacopia open Richmond labs to develop new pharma techniques
The Richmond area partnership that’s been working to revolutionize U.S. drug making has reached another milestone with the opening of a new lab space…
Read More
Precigen Announces Positive Phase 1 Dose Escalation Data for Autologous PRGN-3006 UltraCAR-T® Manufactured Overnight for Next Day Infusion in Relapsed or Refractory Acute Myeloid Leukemia Patients
– Single infusion of UltraCAR-T cells with or without lymphodepletion demonstrated robust expansion and persistence in blood and bone marrow – – PRGN-3006 infusion…
Read More
The ‘John Holaday’ BioHealth Leadership Award: Dr. Kurt Newman, President & CEO, Children’s National Hospital
In honor of the late John Holaday, Ph.D., renowned scientist, CEO, philanthropist, mentor, and community leader, this award recognizes a regional biohealth leader who…
Read More
The BioBuzz Media Award: American Gene Technologies® “The Cure Chronicles” Video Series
This award honors a media campaign that most aligns with our mission; ‘to create exceptional experiences that better connect people and employers and foster…
Read More
The Breakthrough Life Science Company of the Year Award: Vaccitech
This award recognizes the companies who have pursued their mission with dedication and perseverance and built momentum towards commercialization with a substantial breakthrough this…
Read More
BHI’s New BHI Executives-In-Residence Featured on BioTalk
New BHI Executives-In-Residence, Jennifer Butler and Luis Gutierrez, join VP Economic Development Sarah Miller on BioTalk with Rich Bendis to discuss the recent launch…
Read More
USP Launches R&D Analytical Solutions To Advance Continuous Manufacturing Technologies
USP Advanced Manufacturing Technology Lab Opens in Richmond, Virginia Rockville, MD, December 12, 2022 – The U.S. Pharmacopeia (USP) today announced the opening of…
Read More
Amgen Agrees to Deal to Buy Horizon Therapeutics – WSJ
The U.S. biotechnology company will pay $116.50 for each Horizon share Amgen Inc. has agreed to acquire Horizon Therapeutics PLC in an all-cash deal valued…
Read More
Emmes launches cell and gene therapy centre
Emmes, a global, full-service clinical research organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, has announced the creation of…
Read More
Updated: Gilead, Arcellx team up on anti-BCMA CAR-T as biotech touts a 100% response rate at #ASH22 – Endpoints News
Gilead and Kite are plunking down big cash to get into the anti-BCMA CAR-T game. The pair will shell out $225 million in cash…
Read More
Arcellx and Kite Announce Strategic Collaboration to Co-Develop and Co-Commercialize Late-Stage Clinical CART-ddBCMA in Multiple Myeloma
REDWOOD CITY, Calif., and SANTA MONICA, Calif., Dec. 9, 2022 /PRNewswire/ -- Arcellx, Inc. (NASDAQ: ACLX) and Kite, a Gilead Company (NASDAQ: GILD), today…
Read More